当前位置:首页 - 行情中心 - 恩威医药(301331) - 财务分析

恩威医药

(301331)

  

流通市值:33.58亿  总市值:33.65亿
流通股本:1.03亿   总股本:1.03亿

恩威医药(301331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.37亿元,每股收益0.37元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益108364.83万元,未分配利润35672.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产149670.88万元,负债41306.05万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入636,853,560449,221,452.75196,499,491.35812,127,431.13
营业总成本603,849,773.06408,252,811.68183,733,734.69763,172,474.47
其他经营收益
营业利润43,356,667.7645,901,404.718,195,945.0849,686,515.99
利润总额43,187,561.4745,729,439.3917,986,639.7446,683,834.32
净利润36,584,661.6738,344,181.2516,305,126.8937,497,544.35
每股收益
其他综合收益----
综合收益总额36,584,661.6738,344,181.2516,305,126.8937,497,544.35
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计937,260,557.13956,378,438.7942,025,659.66952,037,157.23
非流动资产:
非流动资产合计559,448,194.4559,606,358.59554,244,464.41552,491,760.82
资产总计1,496,708,751.531,515,984,797.291,496,270,124.071,504,528,918.05
流动负债:
流动负债合计211,216,454.12232,562,769.89212,532,003.52238,422,148.41
非流动负债:
非流动负债合计201,844,022.66200,542,991.26207,233,151.98208,435,686.15
负债合计413,060,476.78433,105,761.15419,765,155.5446,857,834.56
所有者权益(或股东权益):
归属于母公司股东权益合计1,083,648,274.751,082,879,036.141,076,504,968.571,057,671,083.49
股东权益合计1,083,648,274.751,082,879,036.141,076,504,968.571,057,671,083.49
负债和股东权益合计1,496,708,751.531,515,984,797.291,496,270,124.071,504,528,918.05
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计617,940,375425,210,134.08199,901,802.99749,688,281.63
经营活动现金流出小计541,738,339.99350,027,973.26175,223,677.5670,768,561.8
经营活动产生的现金流量净额76,202,035.0175,182,160.8224,678,125.4978,919,719.83
投资活动产生的现金流量:
投资活动现金流入小计1,267,294,447.06865,450,815.15422,479,327.18957,717,557.13
投资活动现金流出小计1,346,711,793.66904,218,278.07442,453,732.731,068,334,929.94
投资活动产生的现金流量净额-79,417,346.6-38,767,462.92-19,974,405.55-110,617,372.81
筹资活动产生的现金流量:
筹资活动现金流入小计---260,163,611.13
筹资活动现金流出小计26,442,128.1325,580,789.63828,750175,059,041.11
筹资活动产生的现金流量净额-26,442,128.13-25,580,789.63-828,75085,104,570.02
汇率变动对现金及现金等价物的影响-70.8-25.42-8.6990.3
现金及现金等价物净增加额-29,657,510.5210,833,882.853,874,961.2553,407,007.34
期末现金及现金等价物余额259,566,279.03300,057,672.4293,098,750.8289,223,789.55
补充资料:
现金及现金等价物的净增加额-10,833,882.85-53,407,007.34
TOP↑